Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    Have you forgotten your password?
Repository logoRepository logo
  • Communities & Collections
  • All Contents
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Kuvaki B."

Now showing 1 - 2 of 2
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Evaluation of cardiopulmonary resuscitation conditions in turkey: Current status of code blue
    (AVES, 2021) Tezcan Keleş G.; Özbilgin Ş.; Uğur L.; Birbiçer H.; Akın Ş.; Kuvaki B.; Doruk N.; Türkan H.; Akan M.
    Objective: Globally, previously determined teams activated by ‘code blue’ calls target rapid and organised responses to medical emergency situations. This study aimed to evaluate the cardiopulmonary resuscitation (CPR) conditions in Turkey. Methods: A web-based survey was sent to anaesthesiologists in Turkey via email. The survey included 36 questions about demographic features and ‘code blue’ practices and procedures. Results: A total of 180 participants were included. The mean working duration was 16.1±7.5 years. Of the anaesthesiologists who participated, 35% worked in university, 26.1% in education and research, 1.7% in city hospitals, 18.9% in state hospitals and 18.3% in private hospitals; 68.3% had CPR certification. There were code blue systems in 97.6% of the organisations. For code blue calls, 71.9% were activated by calling ‘2222’. There were 41.5% organisations with code blue teams of 3–4 people, whereas 26.7% had 2-member teams. Among call responders, 68.5% were anaesthesia technicians/paramedics, 60.7% were anaesthesiologists and 42.7% were anaesthesia assistants. In organisations, 66.3% regularly conducted code blue training. In total, 63.3% of the participants stated that the time to reach the location was nearly 2–4 minutes. During CPR, the use of capnography was 18.3%. Of the participants, 73.8% chose endotracheal intubation as priority airway device during CPR. Conclusion: Today, code blue practice is an important quality criterion for hospitals. This study shows the current status of ‘code blue’ according to the results of respondent data completing the survey. To prevent in-hospital cardiac arrest, a chain of preventive measures should be established, including personnel training, monitoring of patients, recognition of patient deterioration, the presence of a call for help system and effective intervention. © 2021 by Turkish Society of Anaesthesiology and Reanimation.
  • No Thumbnail Available
    Item
    Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial
    (Springer Science and Business Media Deutschland GmbH, 2024) Meersch M.; Weiss R.; Strauß C.; Albert F.; Booke H.; Forni L.; Pittet J.; Kellum J.A.; Rosner M.; Mehta R.; Bellomo R.; Rosenberger P.; Zarbock A.; Makhloufi H.; Sakhraoui R.; Ouyahia A.; Rais M.; Kouicem A.T.; Derwish K.; Abdoun M.; Ouahab I.; Bouaoud S.; Tidjane A.; Pérez Rivera C.J.; García J.P.; Peng K.; Ji F.-H.; Ma Z.-M.; Elbahnasawy M.G.; Elsalhawy S.; Nafea A.M.; Osman N.A.; Emara M.M.; Bonna M.M.; Abdehaleem I.A.; Abbas A.M.; Abbas M.S.; Esmaeil H.M.; Joannes-Boyau O.; Legros V.; Floch T.; Muccio S.; Menage-Innocenti L.; Brochet B.; Leclercq-Rouget M.; Geneve C.; Mocarquer B.V.; Aveline C.; Vautier P.; Nadaud J.; Rimmelé T.; Cerro V.; Suria S.; Elmawieh J.; El-Jawiche R.; Cirenei C.; Lebuffe G.; Ponsonnard S.; Egreteau P.-Y.; Ichai C.; Jean-Michel V.; Léger M.; Lasocki S.; Masson C.; Rineau E.; Cassisa V.; Verrier P.; Atchade E.; Rochon C.-E.; Quentin V.; Queixalos N.; Braun T.; Grand H.; Mayeur N.; Pasquie M.; Garçon P.; Bruckert V.; Pradel G.; Ramorasata A.; Ravry C.; Mottard N.; von Groote T.; Dörr C.; Küllmar M.; Massoth C.; Motekallemi A.; Saadat-Gilani K.; Kerschke L.; Storck M.; Varghese J.; Wempe C.; Grüßer L.; Kowark A.; Brandenburger T.; Hohn A.; Häberle H.; Hofmann P.; Kuhle J.; Calov S.; Bernard A.M.; Mirakaj V.; Weber K.; Pfister K.; Stetz L.; Müller S.D.; Klaus S.; Sadlo M.; Sengelhoff C.; Stenger C.-K.; Göbel U.; Heringlake M.; Arnaoutoglou E.; Stratigopoulou P.; Danai P.; Dimakopoulou A.; Menis A.-A.; Ioannidis O.; Jalaawiy H.; Anwar A.; Hashim H.T.; Rasheed Aldawoody H.I.; Cortegiani A.; Ippolito M.; Marino C.; Presti G.; Fricano D.C.; De Rosa S.; Bianchin A.; Paternoster G.; Fasciano U.; Cutuli S.L.; Savino S.; Enrico B.; Marco P.; Alberto V.C.; Tripodi V.F.; Fiume D.; Iuorio A.; Santorsola C.; Abu-Hussein B.; Hasanein K.; Shin S.; Baek J.; Kim S.; Elhadi M.; Aldressi W.; Abuzeid I.A.; Albaraesi M.N.; Moftah M.A.; Aldressi S.; Khalel W.; Abdulwahed E.; Ali Alshareea E.A.; Abujrad Reem Ghmagh A.A.A.; Biala M.I.; Benjouira R.A.I.; Aliwa M.; Msherghi A.; Tuwaib A.; Mustafa T.; Zriba H.; Agilla H.M.; Sadek Ben Hamida B.T.; Mohamed Otman R.H.; Mijovska M.M.; Podesta A.M.C.; Gasca López G.A.; Amro S.; de Freitas Regufe R.; Grigoryev E.; Ivkin A.; Balakhnin D.; Shukevich D.; Yaroustovsky M.; Barmou A.; Kaserer A.; Castellucci C.; Akbas S.; Petrun A.M.; Gregorcic I.; Sok V.; Links A.; Barreto E.B.; Melchor J.R.; Becerra-Bolaños Á.; Rodríguez-Pérez A.; Estévez J.M.; Matas J.M.; Palao S.P.; Álvarez M.G.; Albadalejo A.B.; González A.B.; Caro A.M.G.; Blanco I.H.; Fernandez D.T.; Perez G.H.; Ejea M.L.; de la Rosa Ruiz N.; Abasolo M.G.; Ferreira L.; Lobato F.; Sevilla M.A.; Erazo A.; Paulis B.C.; de la Calle Gil I.; Adamove P.; Blasco F.M.B.; García-Sánchez J.I.; Zamorano S.G.; Herreros N.G.; Callejas R.; Gómez M.E.; Candela-Toha A.M.; Claros-Llamas E.; Cobeta-Orduña P.; Crespo-Aliseda P.; Dorado-Díaz T.; Gómez-Rojo M.; Mané-Ruiz M.N.; González M.C.M.; Martínez-Pérez A.; Tiscar C.; Menéndez P.G.; Calvo V.E.; Espí L.L.; Aldeán Y.S.L.; Ariza V.M.; Vila L.V.; García-Miguel F.J.; Suliman E.S.M.; Ibrahim A.M.; Fadlalmola H.A.; Swed S.; Wu V.-C.; Orhan-Sungur M.; Altun D.; Canbolat N.; Dinçer M.B.; Yildirim S.A.; Iyigun M.; Yapıcı D.; Özdemir L.; Sagün A.; Boztug N.; Gündüz E.; Lafli-Tunay D.; Karakaya D.; Dost B.; Komurcu O.; Dilmen O.K.; Akcil E.F.; Tunali Y.; Ok G.; Tok-Alsina E.; Polat C.; Kızılcık N.; Şen Ö.; Darçın K.; Uğur S.; Gürkan Y.; Saracoglu K.T.; Yıldız-Koyuncu Ö.; Demir Z.A.; Postacı N.A.; Özgök A.; Karadeniz Ü.; Özay H.Y.; Balcı E.; Salman N.; Girgin B.; Sagir O.; Demir H.F.; Ugun F.; Toprak H.İ.; Özcan M.S.; Alkaya-Solmaz F.; Yilmaz M.; Karaca U.; Şahin S.H.; Erkoç S.K.; Alkış N.; Baytaş V.; Erturk E.; Saylan S.; Akdogan A.; Yeşil B.B.; Boran O.F.; Orak Y.; Çalişir F.; Büyükçoban S.; Kuvaki B.; Cansabuncu S.; Akesen S.; Gören S.; Yeniocak T.; Orman O.; Karka Ö.E.; Sahin T.; Momot N.; Panchenko A.; Rutledge K.
    Purpose: Acute kidney disease (AKD) is a significant health care burden worldwide. However, little is known about this complication after major surgery. Methods: We conducted an international prospective, observational, multi-center study among patients undergoing major surgery. The primary study endpoint was the incidence of AKD (defined as new onset of estimated glomerular filtration rate (eCFR) < 60 ml/min/1.73 m2 present on day 7 or later) among survivors. Secondary endpoints included the relationship between early postoperative acute kidney injury (AKI) (within 72 h after major surgery) and subsequent AKD, the identification of risk factors for AKD, and the rate of chronic kidney disease (CKD) progression in patients with pre-existing CKD. Results: We studied 9510 patients without pre-existing CKD. Of these, 940 (9.9%) developed AKD after 7 days of whom 34.1% experiencing an episode of early postoperative-AKI. Rates of AKD after 7 days significantly increased with the severity (19.1% Kidney Disease Improving Global Outcomes [KDIGO] 1, 24.5% KDIGO2, 34.3% KDIGO3; P < 0.001) and duration (15.5% transient vs 38.3% persistent AKI; P < 0.001) of early postoperative-AKI. Independent risk factors for AKD included early postoperative-AKI, exposure to perioperative nephrotoxic agents, and postoperative pneumonia. Early postoperative-AKI carried an independent odds ratio for AKD of 2.64 (95% confidence interval [CI] 2.21–3.15). Of 663 patients with pre-existing CKD, 42 (6.3%) had worsening CKD at day 90. In patients with CKD and an episode of early AKI, CKD progression occurred in 11.6%. Conclusion: One in ten major surgery patients developed AKD beyond 7 days after surgery, in most cases without an episode of early postoperative-AKI. However, early postoperative-AKI severity and duration were associated with an increased rate of AKD and early postoperative-AKI was strongly associated with AKD independent of all other potential risk factors. © The Author(s) 2024.

Manisa Celal Bayar University copyright © 2002-2025 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback